ramucirumab,pembrolizumab
eli lilly,merck
['lcsm,(-blcsm)', 'lung']
the consortium (which includes patient advocates) is reporting positive data for lung cancers that have progressed after immunotherapy: better survival and less toxicity #asco22 #lcsm 
Dedicated to saving, extending, and improving the lives of those vulnerable, at risk, and diagnosed with #lungcancer.